General Archive

Home » Featured » Page 4
  • Microbiology, technician working with bacteria strains
    News releases

    LifeArc joins forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to strengthen antimicrobial discovery efforts

    Pivotal partnership seeks to transform Cystic Fibrosis research 

    Read more

  • Eczema dermatitis on hands and feet.
    Ventures funding, News releases

    LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million

    First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its science

    Read more

  • Escherichia Coli (E. Coli.) cells or bacteria under microscope
    News releases

    LifeArc helps create new MRC spin-out company

    The new company aims to re-programme microbes to enable new materials to be produced – such as drugs and biodegradable…

    Read more

  • Woman and child waling into the entrance of the Great Ormond Street Hospital
    News releases

    Driving translational research into childhood rare diseases

    Four grants awarded to projects that aim to translate research discoveries into benefits for children affected by rare diseases

    Read more

  • David Setters, who is living with MND
    News releases

    New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease

    Collaboration will work together to find solutions to MND within years, not decades

    Read more

  • Older patient with carer
    News releases

    New £30 million translational partnership will accelerate development of new treatments for people with dementia

    Funding will accelerate development of new diagnostic tests, treatments, and devices for people with dementia.

    Read more

  • Scientist in the antibody humanisation lab at LifeArc
    News releases

    Promising new asthma medicine ready to enter early clinical trials

    LifeArc scientists instrumental to the development of the world’s first anti-IL17BR antibody, now being trialled as a treatment for severe…

    Read more

  • News releases, Ventures funding

    LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

    LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has…

    Read more

  • Maree-Todd headshot
    News releases

    LifeArc and Scottish Government work together to drive Scottish research into rare diseases

    LifeArc and the Chief Scientist Office (CSO) for the Scottish Government have today jointly awarded a total of £300,000 to…

    Read more

  • DNA molecule spiral with unique connection. 3d rendered illustration
    News releases

    Study reveals gene faults underpinning severe COVID-19

    The study paves the way for new tests and treatments to protect people from infection.

    Read more

  • Articles & blogs

    LifeArc – advancing innovation in rare disease

    We act as a trusted partner to transform the way rare diseases are identified and treated.

    Read more

  • News releases

    LifeArc elects new Board Chair to drive charity’s ambitious strategy

    Dr Ian Gilham appointed new Chair of Trustees to succeed Dr John Stageman when he steps down on 4 April…

    Read more